| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 2.14e-11 | 20 | 60 | 6 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.03e-09 | 36 | 60 | 6 | GO:0019789 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 8.17e-09 | 50 | 60 | 6 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.17e-08 | 53 | 60 | 6 | GO:0016859 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | CDK8 RGPD4 RGPD2 RANBP2 UBE2K RGPD8 FBXO44 RGPD3 RGPD1 HECTD1 | 2.74e-07 | 398 | 60 | 10 | GO:0061659 |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | CDK8 RGPD4 RGPD2 RANBP2 UBE2K RGPD8 FBXO44 RGPD3 RGPD1 HECTD1 | 2.69e-06 | 512 | 60 | 10 | GO:0019787 |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | CDK8 RGPD4 RGPD2 RANBP2 UBE2K RGPD8 FBXO44 RGPD3 RGPD1 HECTD1 | 3.77e-06 | 532 | 60 | 10 | GO:0016755 |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.98e-05 | 279 | 60 | 7 | GO:0005096 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 2.38e-05 | 192 | 60 | 6 | GO:0008234 | |
| GeneOntologyMolecularFunction | isomerase activity | 2.38e-05 | 192 | 60 | 6 | GO:0016853 | |
| GeneOntologyMolecularFunction | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism | 4.99e-05 | 24 | 60 | 3 | GO:0044769 | |
| GeneOntologyMolecularFunction | proton-transporting ATPase activity, rotational mechanism | 4.99e-05 | 24 | 60 | 3 | GO:0046961 | |
| GeneOntologyMolecularFunction | ATPase-coupled ion transmembrane transporter activity | 4.99e-05 | 24 | 60 | 3 | GO:0042625 | |
| GeneOntologyMolecularFunction | acyltransferase activity | CDK8 RGPD4 RGPD2 RANBP2 UBE2K RGPD8 FBXO44 RGPD3 RGPD1 HECTD1 | 9.50e-05 | 775 | 60 | 10 | GO:0016746 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 1.31e-04 | 507 | 60 | 8 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 1.31e-04 | 507 | 60 | 8 | GO:0030695 | |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 3.84e-04 | 114 | 60 | 4 | GO:0004843 | |
| GeneOntologyMolecularFunction | small GTPase binding | 3.97e-04 | 321 | 60 | 6 | GO:0031267 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 5.28e-04 | 124 | 60 | 4 | GO:0101005 | |
| GeneOntologyMolecularFunction | GTPase binding | 7.26e-04 | 360 | 60 | 6 | GO:0051020 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 7.37e-04 | 656 | 60 | 8 | GO:0008047 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 7.68e-04 | 137 | 60 | 4 | GO:0019783 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 8.60e-04 | 62 | 60 | 3 | GO:0019829 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 2.21e-03 | 86 | 60 | 3 | GO:0004197 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 2.66e-03 | 627 | 60 | 7 | GO:0022890 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | RGPD4 RGPD2 RANBP2 EGF RGPD8 RGPD3 CAPN3 RGPD1 MCRS1 CABIN1 RGPD5 | 3.02e-03 | 1418 | 60 | 11 | GO:0030234 |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 3.42e-03 | 29 | 60 | 2 | GO:0005540 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 3.66e-03 | 30 | 60 | 2 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 3.66e-03 | 30 | 60 | 2 | GO:0097472 | |
| GeneOntologyMolecularFunction | ATPase binding | 4.21e-03 | 108 | 60 | 3 | GO:0051117 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 4.32e-03 | 109 | 60 | 3 | GO:0042626 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 4.42e-03 | 33 | 60 | 2 | GO:0005217 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 3.52e-14 | 9 | 59 | 6 | GO:0033133 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 8.16e-14 | 20 | 59 | 7 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 8.78e-14 | 10 | 59 | 6 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 7.12e-13 | 13 | 59 | 6 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.24e-12 | 14 | 59 | 6 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.08e-09 | 38 | 59 | 6 | GO:0000413 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 9.80e-09 | 54 | 59 | 6 | GO:0018208 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 5.23e-08 | 71 | 59 | 6 | GO:0006111 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 9.69e-08 | 132 | 59 | 7 | GO:0043255 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 7.57e-07 | 111 | 59 | 6 | GO:0006094 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 9.33e-07 | 115 | 59 | 6 | GO:0019319 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 1.26e-06 | 121 | 59 | 6 | GO:0046364 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 1.36e-06 | 195 | 59 | 7 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 1.67e-06 | 201 | 59 | 7 | GO:0051170 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 2.28e-06 | 134 | 59 | 6 | GO:0010906 | |
| GeneOntologyBiologicalProcess | mRNA transport | 3.61e-06 | 145 | 59 | 6 | GO:0051028 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 4.20e-06 | 231 | 59 | 7 | GO:0006109 | |
| GeneOntologyBiologicalProcess | carbohydrate biosynthetic process | 6.51e-06 | 247 | 59 | 7 | GO:0016051 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 8.47e-06 | 362 | 59 | 8 | GO:0034504 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | RGPD4 RGPD2 RANBP2 GPAA1 EGF RGPD8 RGPD3 HGS RGPD1 TCIRG1 MCRS1 CROCC RGPD5 | 9.84e-06 | 1091 | 59 | 13 | GO:0033365 |
| GeneOntologyBiologicalProcess | RNA transport | 1.06e-05 | 175 | 59 | 6 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.06e-05 | 175 | 59 | 6 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.17e-05 | 178 | 59 | 6 | GO:0051236 | |
| GeneOntologyBiologicalProcess | nuclear export | 1.46e-05 | 185 | 59 | 6 | GO:0051168 | |
| GeneOntologyBiologicalProcess | RNA localization | 3.58e-05 | 217 | 59 | 6 | GO:0006403 | |
| GeneOntologyBiologicalProcess | protein catabolic process | UBE2K EGF FBXO44 CAPN3 HGS USP17L24 OSBPL7 USP17L6P TCIRG1 HECTD1 MAN1B1 PCYOX1 | 6.20e-05 | 1115 | 59 | 12 | GO:0030163 |
| GeneOntologyBiologicalProcess | glucose metabolic process | 6.87e-05 | 244 | 59 | 6 | GO:0006006 | |
| GeneOntologyBiologicalProcess | protein folding | 7.19e-05 | 246 | 59 | 6 | GO:0006457 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 7.69e-05 | 249 | 59 | 6 | GO:0015931 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | 8.50e-05 | 646 | 59 | 9 | GO:0005975 | |
| GeneOntologyBiologicalProcess | proteolysis involved in protein catabolic process | UBE2K EGF FBXO44 HGS USP17L24 OSBPL7 USP17L6P HECTD1 MAN1B1 PCYOX1 | 9.24e-05 | 812 | 59 | 10 | GO:0051603 |
| GeneOntologyBiologicalProcess | nuclear transport | 9.87e-05 | 378 | 59 | 7 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 9.87e-05 | 378 | 59 | 7 | GO:0006913 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | 1.04e-04 | 515 | 59 | 8 | GO:0072594 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | 1.20e-04 | 676 | 59 | 9 | GO:0044283 | |
| GeneOntologyBiologicalProcess | vacuolar acidification | 1.48e-04 | 36 | 59 | 3 | GO:0007035 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 1.51e-04 | 405 | 59 | 7 | GO:0033674 | |
| GeneOntologyBiologicalProcess | hexose metabolic process | 1.58e-04 | 284 | 59 | 6 | GO:0019318 | |
| GeneOntologyBiologicalProcess | protein deubiquitination involved in ubiquitin-dependent protein catabolic process | 2.23e-04 | 8 | 59 | 2 | GO:0071947 | |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | 2.53e-04 | 310 | 59 | 6 | GO:0005996 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | 4.52e-04 | 125 | 59 | 4 | GO:0016579 | |
| GeneOntologyBiologicalProcess | regulation of transferase activity | 4.58e-04 | 810 | 59 | 9 | GO:0051338 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | 4.80e-04 | 490 | 59 | 7 | GO:0051347 | |
| GeneOntologyBiologicalProcess | modification-dependent protein catabolic process | 5.06e-04 | 651 | 59 | 8 | GO:0019941 | |
| GeneOntologyBiologicalProcess | modification-dependent macromolecule catabolic process | 5.32e-04 | 656 | 59 | 8 | GO:0043632 | |
| GeneOntologyBiologicalProcess | intracellular pH reduction | 6.13e-04 | 58 | 59 | 3 | GO:0051452 | |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 6.15e-04 | 13 | 59 | 2 | GO:0072488 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | 7.13e-04 | 686 | 59 | 8 | GO:0043549 | |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | 7.70e-04 | 144 | 59 | 4 | GO:0070646 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | 1.16e-03 | 740 | 59 | 8 | GO:0006886 | |
| GeneOntologyBiologicalProcess | regulation of small molecule metabolic process | 1.47e-03 | 434 | 59 | 6 | GO:0062012 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | 1.62e-03 | 780 | 59 | 8 | GO:0042327 | |
| GeneOntologyBiologicalProcess | positive regulation of type I interferon-mediated signaling pathway | 1.63e-03 | 21 | 59 | 2 | GO:0060340 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | 1.71e-03 | 976 | 59 | 9 | GO:0018193 | |
| GeneOntologyBiologicalProcess | optic nerve development | 1.79e-03 | 22 | 59 | 2 | GO:0021554 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.21e-14 | 8 | 60 | 6 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 9.00e-14 | 10 | 60 | 6 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.28e-12 | 14 | 60 | 6 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 7.81e-12 | 18 | 60 | 6 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.62e-11 | 20 | 60 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 2.27e-11 | 21 | 60 | 6 | GO:0106068 | |
| GeneOntologyCellularComponent | inclusion body | 6.94e-09 | 90 | 60 | 7 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear pore | 1.56e-08 | 101 | 60 | 7 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear membrane | 6.35e-07 | 349 | 60 | 9 | GO:0031965 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | RGPD4 TSNAXIP1 RGPD2 RANBP2 ATP6V0A1 RGPD8 RGPD3 CDK19 USP29 RGPD1 OSBPL7 ATP6V0A2 ITPR1 | 1.91e-06 | 934 | 60 | 13 | GO:0048471 |
| GeneOntologyCellularComponent | vacuolar proton-transporting V-type ATPase, V0 domain | 2.66e-06 | 10 | 60 | 3 | GO:0000220 | |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD1 OSBPL7 ACKR2 ITPR1 RGPD5 | 3.97e-06 | 560 | 60 | 10 | GO:0005635 |
| GeneOntologyCellularComponent | proton-transporting V-type ATPase, V0 domain | 4.86e-06 | 12 | 60 | 3 | GO:0033179 | |
| GeneOntologyCellularComponent | vacuolar proton-transporting V-type ATPase complex | 5.58e-05 | 26 | 60 | 3 | GO:0016471 | |
| GeneOntologyCellularComponent | proton-transporting two-sector ATPase complex, proton-transporting domain | 5.58e-05 | 26 | 60 | 3 | GO:0033177 | |
| GeneOntologyCellularComponent | proton-transporting V-type ATPase complex | 7.79e-05 | 29 | 60 | 3 | GO:0033176 | |
| GeneOntologyCellularComponent | CKM complex | 8.06e-05 | 5 | 60 | 2 | GO:1990508 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | RGPD4 RGPD2 RANBP2 GPAA1 RGPD8 RGPD3 RGPD1 OSBPL7 USP17L6P USP17L5 MAN1B1 ITPR1 | 3.32e-04 | 1327 | 60 | 12 | GO:0042175 |
| GeneOntologyCellularComponent | cation-transporting ATPase complex | 3.77e-04 | 49 | 60 | 3 | GO:0090533 | |
| GeneOntologyCellularComponent | transferase complex | CDK8 RGPD4 RGPD2 RANBP2 RGPD8 FBXO44 RGPD3 CDK19 RGPD1 MCRS1 | 3.81e-04 | 963 | 60 | 10 | GO:1990234 |
| GeneOntologyCellularComponent | proton-transporting two-sector ATPase complex | 4.76e-04 | 53 | 60 | 3 | GO:0016469 | |
| GeneOntologyCellularComponent | ATPase complex | 5.17e-04 | 129 | 60 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | ATPase dependent transmembrane transport complex | 5.30e-04 | 55 | 60 | 3 | GO:0098533 | |
| GeneOntologyCellularComponent | endocytic vesicle | 8.02e-04 | 384 | 60 | 6 | GO:0030139 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 1.08e-03 | 157 | 60 | 4 | GO:0045335 | |
| GeneOntologyCellularComponent | nuclear cyclin-dependent protein kinase holoenzyme complex | 1.20e-03 | 18 | 60 | 2 | GO:0019908 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | CDK8 RGPD4 RGPD2 RANBP2 RGPD8 NELFCD RGPD3 CDK19 RGPD1 MCRS1 RGPD5 | 1.68e-03 | 1377 | 60 | 11 | GO:0140513 |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 1.75e-03 | 83 | 60 | 3 | GO:0030670 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 3.22e-03 | 212 | 60 | 4 | GO:0030666 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 5.33e-12 | 16 | 44 | 6 | MP:0003701 | |
| MousePheno | abnormal morula morphology | 1.50e-10 | 26 | 44 | 6 | MP:0012058 | |
| MousePheno | decreased tumor latency | 3.83e-10 | 30 | 44 | 6 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 4.74e-10 | 31 | 44 | 6 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 8.59e-10 | 34 | 44 | 6 | MP:0010307 | |
| MousePheno | abnormal blastocyst formation | 2.06e-09 | 39 | 44 | 6 | MP:0012128 | |
| MousePheno | enlarged epididymis | 2.23e-08 | 99 | 44 | 7 | MP:0004931 | |
| MousePheno | aneuploidy | 3.33e-08 | 61 | 44 | 6 | MP:0004024 | |
| MousePheno | abnormal epididymis size | 4.11e-08 | 166 | 44 | 8 | MP:0004926 | |
| MousePheno | increased hepatocellular carcinoma incidence | 7.70e-08 | 70 | 44 | 6 | MP:0003331 | |
| MousePheno | increased lung carcinoma incidence | 1.48e-07 | 78 | 44 | 6 | MP:0008714 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 1.95e-07 | 203 | 44 | 8 | MP:0011094 | |
| MousePheno | abnormal chromosome number | 2.66e-07 | 86 | 44 | 6 | MP:0004023 | |
| MousePheno | increased sarcoma incidence | 7.34e-07 | 102 | 44 | 6 | MP:0002032 | |
| MousePheno | embryonic lethality before implantation | 7.44e-07 | 242 | 44 | 8 | MP:0006204 | |
| MousePheno | abnormal preimplantation embryo development | 9.49e-07 | 171 | 44 | 7 | MP:0009781 | |
| MousePheno | increased lung tumor incidence | 9.73e-07 | 107 | 44 | 6 | MP:0008014 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 9.73e-07 | 107 | 44 | 6 | MP:0003694 | |
| MousePheno | increased respiratory system tumor incidence | 9.73e-07 | 107 | 44 | 6 | MP:0010298 | |
| MousePheno | increased liver tumor incidence | 1.21e-06 | 111 | 44 | 6 | MP:0008019 | |
| MousePheno | increased hepatobiliary system tumor incidence | 1.21e-06 | 111 | 44 | 6 | MP:0010297 | |
| MousePheno | abnormal blastocyst hatching | 1.34e-06 | 113 | 44 | 6 | MP:0003693 | |
| MousePheno | abnormal epididymis morphology | 1.65e-06 | 269 | 44 | 8 | MP:0002631 | |
| MousePheno | abnormal rod electrophysiology | 1.82e-06 | 119 | 44 | 6 | MP:0004021 | |
| MousePheno | abnormal chromosome morphology | 2.54e-06 | 126 | 44 | 6 | MP:0003702 | |
| MousePheno | abnormal mitosis | 2.78e-06 | 128 | 44 | 6 | MP:0004046 | |
| MousePheno | increased incidence of tumors by chemical induction | 4.87e-06 | 141 | 44 | 6 | MP:0004499 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 1.01e-05 | 160 | 44 | 6 | MP:0005659 | |
| MousePheno | impaired glucose tolerance | 1.50e-05 | 480 | 44 | 9 | MP:0005293 | |
| MousePheno | increased incidence of induced tumors | 1.57e-05 | 173 | 44 | 6 | MP:0002021 | |
| MousePheno | abnormal cell nucleus morphology | 2.23e-05 | 184 | 44 | 6 | MP:0003111 | |
| MousePheno | decreased susceptibility to weight gain | 2.37e-05 | 186 | 44 | 6 | MP:0010182 | |
| MousePheno | abnormal preimplantation embryo morphology | 2.61e-05 | 283 | 44 | 7 | MP:0014137 | |
| MousePheno | increased energy expenditure | 3.19e-05 | 196 | 44 | 6 | MP:0004889 | |
| MousePheno | increased carcinoma incidence | 3.28e-05 | 197 | 44 | 6 | MP:0002038 | |
| MousePheno | abnormal eye electrophysiology | 7.41e-05 | 228 | 44 | 6 | MP:0005551 | |
| MousePheno | increased malignant tumor incidence | 9.18e-05 | 237 | 44 | 6 | MP:0002018 | |
| MousePheno | opisthotonus | 9.62e-05 | 5 | 44 | 2 | MP:0002880 | |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | CDK8 RGPD4 RGPD2 RANBP2 ATP6V0A1 RGPD8 RGPD3 RGPD1 MCRS1 TBXT | 1.11e-04 | 772 | 44 | 10 | MP:0014259 |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | CDK8 RGPD4 RGPD2 RANBP2 ATP6V0A1 RGPD8 RGPD3 RGPD1 MCRS1 TBXT | 1.20e-04 | 779 | 44 | 10 | MP:0014257 |
| MousePheno | abnormal glucose tolerance | RGPD4 PALD1 RGPD2 RANBP2 RGPD8 RGPD3 RGPD1 LPAR1 NEUROG3 ITPR1 | 1.30e-04 | 787 | 44 | 10 | MP:0005291 |
| MousePheno | abnormal incidence of induced tumors | 1.83e-04 | 269 | 44 | 6 | MP:0013151 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 2.56e-04 | 286 | 44 | 6 | MP:0008873 | |
| MousePheno | abnormal susceptibility to weight gain | 3.87e-04 | 309 | 44 | 6 | MP:0011117 | |
| MousePheno | abnormal energy expenditure | 4.14e-04 | 313 | 44 | 6 | MP:0005450 | |
| MousePheno | abnormal energy homeostasis | 4.81e-04 | 322 | 44 | 6 | MP:0005448 | |
| MousePheno | embryonic lethality prior to tooth bud stage | CDK8 RGPD4 RGPD2 RANBP2 ATP6V0A1 GPAA1 RGPD8 RGPD3 HGS RGPD1 MCRS1 TBXT | 8.76e-04 | 1383 | 44 | 12 | MP:0013293 |
| MousePheno | embryonic lethality prior to organogenesis | CDK8 RGPD4 RGPD2 RANBP2 ATP6V0A1 RGPD8 RGPD3 HGS RGPD1 MCRS1 TBXT | 9.92e-04 | 1204 | 44 | 11 | MP:0013292 |
| MousePheno | increased classified tumor incidence | 1.16e-03 | 381 | 44 | 6 | MP:0010273 | |
| MousePheno | abnormal classified tumor incidence | 1.21e-03 | 384 | 44 | 6 | MP:0020188 | |
| MousePheno | increased organ/body region tumor incidence | 1.39e-03 | 395 | 44 | 6 | MP:0010274 | |
| MousePheno | abnormal intracellular organelle morphology | 1.46e-03 | 546 | 44 | 7 | MP:0014239 | |
| MousePheno | abnormal organ/body region tumor incidence | 1.51e-03 | 401 | 44 | 6 | MP:0013152 | |
| MousePheno | impaired swimming | 2.02e-03 | 80 | 44 | 3 | MP:0001522 | |
| MousePheno | abnormal lung morphology | 2.42e-03 | 767 | 44 | 8 | MP:0001175 | |
| Domain | Ran_BP1 | 1.16e-15 | 12 | 56 | 7 | PF00638 | |
| Domain | RANBD1 | 1.16e-15 | 12 | 56 | 7 | PS50196 | |
| Domain | RanBD | 2.50e-15 | 13 | 56 | 7 | SM00160 | |
| Domain | Ran_bind_dom | 2.50e-15 | 13 | 56 | 7 | IPR000156 | |
| Domain | GRIP | 2.52e-13 | 11 | 56 | 6 | PF01465 | |
| Domain | Grip | 2.52e-13 | 11 | 56 | 6 | SM00755 | |
| Domain | GRIP_dom | 5.02e-13 | 12 | 56 | 6 | IPR000237 | |
| Domain | GRIP | 5.02e-13 | 12 | 56 | 6 | PS50913 | |
| Domain | GCC2_Rab_bind | 4.22e-12 | 7 | 56 | 5 | IPR032023 | |
| Domain | Rab_bind | 4.22e-12 | 7 | 56 | 5 | PF16704 | |
| Domain | - | 5.03e-11 | 10 | 56 | 5 | 1.10.220.60 | |
| Domain | TPR | 1.40e-09 | 165 | 56 | 9 | PS50005 | |
| Domain | TPR_REGION | 1.40e-09 | 165 | 56 | 9 | PS50293 | |
| Domain | TPR-contain_dom | 1.47e-08 | 150 | 56 | 8 | IPR013026 | |
| Domain | TPR-like_helical_dom | 2.85e-08 | 233 | 56 | 9 | IPR011990 | |
| Domain | V-type_ATPase_116kDa_su_euka | 1.02e-07 | 4 | 56 | 3 | IPR026028 | |
| Domain | V_ATPase_I | 1.02e-07 | 4 | 56 | 3 | PF01496 | |
| Domain | V-ATPase_116kDa_su | 1.02e-07 | 4 | 56 | 3 | IPR002490 | |
| Domain | TPR | 1.11e-07 | 129 | 56 | 7 | SM00028 | |
| Domain | TPR_repeat | 1.37e-07 | 133 | 56 | 7 | IPR019734 | |
| Domain | - | 1.79e-07 | 207 | 56 | 8 | 1.25.40.10 | |
| Domain | PH_dom-like | 4.50e-06 | 426 | 56 | 9 | IPR011993 | |
| Domain | - | 2.03e-05 | 391 | 56 | 8 | 2.30.29.30 | |
| Domain | TPR_1 | 1.53e-04 | 90 | 56 | 4 | PF00515 | |
| Domain | TPR_1 | 1.53e-04 | 90 | 56 | 4 | IPR001440 | |
| Domain | Oxysterol_BP | 5.72e-04 | 12 | 56 | 2 | PF01237 | |
| Domain | Oxysterol-bd | 5.72e-04 | 12 | 56 | 2 | IPR000648 | |
| Domain | Oxysterol-bd_CS | 5.72e-04 | 12 | 56 | 2 | IPR018494 | |
| Domain | OSBP | 5.72e-04 | 12 | 56 | 2 | PS01013 | |
| Domain | USP_CS | 1.02e-03 | 66 | 56 | 3 | IPR018200 | |
| Domain | HABP4_PAI-RBP1 | 1.03e-03 | 16 | 56 | 2 | PF04774 | |
| Domain | HABP4_PAIRBP1-bd | 1.03e-03 | 16 | 56 | 2 | IPR006861 | |
| Domain | TF_T-box | 1.17e-03 | 17 | 56 | 2 | IPR001699 | |
| Domain | TBOX_3 | 1.17e-03 | 17 | 56 | 2 | PS50252 | |
| Domain | TBOX | 1.17e-03 | 17 | 56 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 1.17e-03 | 17 | 56 | 2 | IPR018186 | |
| Domain | T-box | 1.17e-03 | 17 | 56 | 2 | PF00907 | |
| Domain | - | 1.17e-03 | 17 | 56 | 2 | 2.60.40.820 | |
| Domain | TBOX_1 | 1.17e-03 | 17 | 56 | 2 | PS01283 | |
| Domain | TBOX_2 | 1.17e-03 | 17 | 56 | 2 | PS01264 | |
| Domain | USP_1 | 1.21e-03 | 70 | 56 | 3 | PS00972 | |
| Domain | UCH | 1.26e-03 | 71 | 56 | 3 | PF00443 | |
| Domain | USP_2 | 1.26e-03 | 71 | 56 | 3 | PS00973 | |
| Domain | Prefoldin | 1.32e-03 | 72 | 56 | 3 | IPR009053 | |
| Domain | USP_3 | 1.32e-03 | 72 | 56 | 3 | PS50235 | |
| Domain | USP_dom | 1.32e-03 | 72 | 56 | 3 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 1.32e-03 | 72 | 56 | 3 | IPR001394 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.55e-11 | 18 | 46 | 6 | MM1549 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 3.04e-09 | 40 | 46 | 6 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 3.55e-09 | 41 | 46 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 4.13e-09 | 42 | 46 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 4.79e-09 | 43 | 46 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 8.36e-09 | 47 | 46 | 6 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.08e-08 | 49 | 46 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.23e-08 | 50 | 46 | 6 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.39e-08 | 51 | 46 | 6 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.21e-08 | 55 | 46 | 6 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 3.07e-08 | 58 | 46 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 3.07e-08 | 58 | 46 | 6 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 6.15e-08 | 65 | 46 | 6 | MM15147 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.24e-07 | 73 | 46 | 6 | MM14948 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 2.50e-07 | 82 | 46 | 6 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 2.89e-07 | 84 | 46 | 6 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 3.33e-07 | 86 | 46 | 6 | MM15413 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 4.97e-07 | 92 | 46 | 6 | MM14951 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 8.15e-07 | 100 | 46 | 6 | MM14561 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.76e-06 | 114 | 46 | 6 | MM15361 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 2.05e-06 | 117 | 46 | 6 | MM15387 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 3.63e-06 | 129 | 46 | 6 | MM14894 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 6.07e-06 | 141 | 46 | 6 | MM15266 | |
| Pathway | REACTOME_SUMOYLATION | 1.71e-05 | 169 | 46 | 6 | MM14919 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 3.62e-05 | 193 | 46 | 6 | MM14890 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 4.67e-05 | 202 | 46 | 6 | MM15362 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | RGPD4 RGPD2 RANBP2 UBE2K GPAA1 RGPD8 FBXO44 RGPD3 HGS USP29 RGPD1 USP17L6P USP17L5 MCRS1 | 8.83e-05 | 1389 | 46 | 14 | MM15307 |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 1.05e-04 | 234 | 46 | 6 | MM14898 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_RECYCLING | 1.24e-04 | 30 | 46 | 3 | M506 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_RECYCLING | 1.37e-04 | 31 | 46 | 3 | MM15467 | |
| Pathway | REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING | 1.37e-04 | 31 | 46 | 3 | MM15639 | |
| Pathway | REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING | 1.37e-04 | 31 | 46 | 3 | M991 | |
| Pathway | BIOCARTA_EEA1_PATHWAY | 1.55e-04 | 6 | 46 | 2 | MM1577 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 1.76e-04 | 257 | 46 | 6 | MM14755 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 2.02e-04 | 505 | 46 | 8 | MM15548 | |
| Pathway | REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES | 2.15e-04 | 36 | 46 | 3 | M26923 | |
| Pathway | BIOCARTA_EEA1_PATHWAY | 2.16e-04 | 7 | 46 | 2 | M22064 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 2.35e-04 | 271 | 46 | 6 | MM15388 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.35e-04 | 271 | 46 | 6 | MM15406 | |
| Pathway | REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES | 2.53e-04 | 38 | 46 | 3 | MM14519 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.64e-04 | 277 | 46 | 6 | MM15414 | |
| Pathway | KEGG_VIBRIO_CHOLERAE_INFECTION | 7.18e-04 | 54 | 46 | 3 | M17906 | |
| Pathway | REACTOME_IRON_UPTAKE_AND_TRANSPORT | 7.99e-04 | 56 | 46 | 3 | MM15638 | |
| Pathway | REACTOME_IRON_UPTAKE_AND_TRANSPORT | 8.85e-04 | 58 | 46 | 3 | M962 | |
| Pathway | KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION | 1.40e-03 | 68 | 46 | 3 | M16848 | |
| Pathway | REACTOME_M_PHASE | 1.52e-03 | 387 | 46 | 6 | MM15364 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.56e-03 | 532 | 46 | 7 | M27870 | |
| Pathway | REACTOME_DEUBIQUITINATION | 1.57e-03 | 262 | 46 | 5 | MM15286 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 1.94e-03 | 76 | 46 | 3 | MM15442 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.25e-03 | 418 | 46 | 6 | MM15587 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 2.40e-03 | 82 | 46 | 3 | M1021 | |
| Pathway | KEGG_GAP_JUNCTION | 3.13e-03 | 90 | 46 | 3 | M4013 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 3.42e-03 | 191 | 46 | 4 | MM15289 | |
| Pubmed | 1.42e-16 | 7 | 60 | 6 | 21205196 | ||
| Pubmed | 1.42e-16 | 7 | 60 | 6 | 18949001 | ||
| Pubmed | 1.42e-16 | 7 | 60 | 6 | 25187515 | ||
| Pubmed | 1.42e-16 | 7 | 60 | 6 | 9037092 | ||
| Pubmed | 1.42e-16 | 7 | 60 | 6 | 8603673 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.42e-16 | 7 | 60 | 6 | 15710750 | |
| Pubmed | 1.42e-16 | 7 | 60 | 6 | 26632511 | ||
| Pubmed | 1.42e-16 | 7 | 60 | 6 | 24403063 | ||
| Pubmed | 1.42e-16 | 7 | 60 | 6 | 23818861 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.42e-16 | 7 | 60 | 6 | 11353387 | |
| Pubmed | 1.42e-16 | 7 | 60 | 6 | 30944974 | ||
| Pubmed | 1.42e-16 | 7 | 60 | 6 | 38838144 | ||
| Pubmed | 1.42e-16 | 7 | 60 | 6 | 23536549 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.42e-16 | 7 | 60 | 6 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.42e-16 | 7 | 60 | 6 | 17372272 | |
| Pubmed | 1.42e-16 | 7 | 60 | 6 | 38657106 | ||
| Pubmed | 1.42e-16 | 7 | 60 | 6 | 12191015 | ||
| Pubmed | 1.42e-16 | 7 | 60 | 6 | 22821000 | ||
| Pubmed | 1.42e-16 | 7 | 60 | 6 | 20682751 | ||
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 5.69e-16 | 8 | 60 | 6 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 5.69e-16 | 8 | 60 | 6 | 21670213 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 5.69e-16 | 8 | 60 | 6 | 28745977 | |
| Pubmed | 5.69e-16 | 8 | 60 | 6 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 5.69e-16 | 8 | 60 | 6 | 21310149 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.70e-15 | 9 | 60 | 6 | 18394993 | |
| Pubmed | 1.70e-15 | 9 | 60 | 6 | 11553612 | ||
| Pubmed | 1.70e-15 | 9 | 60 | 6 | 10601307 | ||
| Pubmed | 1.70e-15 | 9 | 60 | 6 | 9733766 | ||
| Pubmed | 1.70e-15 | 9 | 60 | 6 | 28100513 | ||
| Pubmed | 1.70e-15 | 9 | 60 | 6 | 28877029 | ||
| Pubmed | 1.70e-15 | 9 | 60 | 6 | 17887960 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 4.26e-15 | 10 | 60 | 6 | 8857542 | |
| Pubmed | 4.26e-15 | 10 | 60 | 6 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 4.26e-15 | 10 | 60 | 6 | 16332688 | |
| Pubmed | 4.26e-15 | 10 | 60 | 6 | 21859863 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 9.35e-15 | 11 | 60 | 6 | 35771867 | |
| Pubmed | 9.35e-15 | 11 | 60 | 6 | 17069463 | ||
| Pubmed | 9.35e-15 | 11 | 60 | 6 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 3.46e-14 | 13 | 60 | 6 | 31427429 | |
| Pubmed | 1.01e-13 | 15 | 60 | 6 | 14697343 | ||
| Pubmed | 1.49e-12 | 22 | 60 | 6 | 27717094 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 5.39e-11 | 38 | 60 | 6 | 12791264 | |
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 12672822 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 10722719 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 10702241 | ||
| Pubmed | 8.61e-09 | 86 | 60 | 6 | 37253089 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 9480752 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 17595521 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 17497178 | ||
| Pubmed | 2.02e-08 | 99 | 60 | 6 | 27746211 | ||
| Pubmed | 4.87e-08 | 5 | 60 | 3 | 35948619 | ||
| Pubmed | Aldolase directly interacts with ARNO and modulates cell morphology and acidic vesicle distribution. | 9.73e-08 | 6 | 60 | 3 | 21307348 | |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 1.28e-07 | 226 | 60 | 7 | 37839992 | |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 1.29e-07 | 135 | 60 | 6 | 31077711 | |
| Pubmed | 1.70e-07 | 7 | 60 | 3 | 20711468 | ||
| Pubmed | Direct recruitment of H+-ATPase from lysosomes for phagosomal acidification. | 1.70e-07 | 7 | 60 | 3 | 19549681 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.05e-07 | 146 | 60 | 6 | 23892456 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 2.70e-07 | 153 | 60 | 6 | 26365490 | |
| Pubmed | 6.04e-07 | 418 | 60 | 8 | 34709266 | ||
| Pubmed | 1.38e-06 | 13 | 60 | 3 | 32001091 | ||
| Pubmed | 1.97e-06 | 215 | 60 | 6 | 35973513 | ||
| Pubmed | Mediator kinase inhibition further activates super-enhancer-associated genes in AML. | 2.93e-06 | 2 | 60 | 2 | 26416749 | |
| Pubmed | CDK8/19 Mediator kinases potentiate induction of transcription by NFκB. | 2.93e-06 | 2 | 60 | 2 | 28855340 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 35181333 | ||
| Pubmed | Regulatory functions of the Mediator kinases CDK8 and CDK19. | 2.93e-06 | 2 | 60 | 2 | 30585107 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 27678455 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 31044597 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 36006697 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 37378433 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 32560467 | ||
| Pubmed | [Mechanisms of transcriptional regulation upon protein phosphorylation by mediator complexes]. | 2.93e-06 | 2 | 60 | 2 | 20408451 | |
| Pubmed | The mutational spectrum of human malignant autosomal recessive osteopetrosis. | 2.93e-06 | 2 | 60 | 2 | 11532986 | |
| Pubmed | Identification of target genes for the CDK subunits of the Mediator complex. | 2.93e-06 | 2 | 60 | 2 | 22117896 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 2.99e-06 | 231 | 60 | 6 | 16452087 | |
| Pubmed | Structures of a Complete Human V-ATPase Reveal Mechanisms of Its Assembly. | 3.26e-06 | 17 | 60 | 3 | 33065002 | |
| Pubmed | The vacuolar (H+)-ATPases--nature's most versatile proton pumps. | 7.34e-06 | 22 | 60 | 3 | 11836511 | |
| Pubmed | 7.34e-06 | 22 | 60 | 3 | 12788495 | ||
| Pubmed | Revised nomenclature for mammalian vacuolar-type H+ -ATPase subunit genes. | 7.34e-06 | 22 | 60 | 3 | 14580332 | |
| Pubmed | Neurotransmitter release: the dark side of the vacuolar-H+ATPase. | 7.34e-06 | 22 | 60 | 3 | 14597263 | |
| Pubmed | 7.34e-06 | 22 | 60 | 3 | 17662945 | ||
| Pubmed | Identification of host proteins required for HIV infection through a functional genomic screen. | 7.61e-06 | 272 | 60 | 6 | 18187620 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 26002960 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 23288846 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 24072707 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 28151579 | ||
| Pubmed | Receptor-mediated endocytosis: the intracellular journey of transferrin and its receptor. | 1.09e-05 | 25 | 60 | 3 | 2874839 | |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | 1.10e-05 | 442 | 60 | 7 | 15815621 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 29440396 | ||
| Pubmed | Cdk8 is required for establishment of H3K27me3 and gene repression by Xist and mouse development. | 1.75e-05 | 4 | 60 | 2 | 32439758 | |
| Pubmed | 2.57e-05 | 33 | 60 | 3 | 20228807 | ||
| Pubmed | 2.81e-05 | 34 | 60 | 3 | 20403174 | ||
| Pubmed | 2.81e-05 | 34 | 60 | 3 | 17109758 | ||
| Pubmed | 2.81e-05 | 34 | 60 | 3 | 20388806 | ||
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | 2.81e-05 | 34 | 60 | 3 | 14699124 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | 2.81e-05 | 34 | 60 | 3 | 20715989 | |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | 2.81e-05 | 34 | 60 | 3 | 9806828 | |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | 2.81e-05 | 34 | 60 | 3 | 20368735 | |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | 2.81e-05 | 34 | 60 | 3 | 15780755 | |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | 2.81e-05 | 34 | 60 | 3 | 19188362 | |
| Pubmed | 2.81e-05 | 34 | 60 | 3 | 11941478 | ||
| Interaction | RGPD4 interactions | 1.63e-13 | 22 | 57 | 7 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 8.40e-13 | 27 | 57 | 7 | int:RGPD2 | |
| Interaction | RGPD3 interactions | 5.70e-11 | 47 | 57 | 7 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 7.75e-11 | 49 | 57 | 7 | int:RGPD1 | |
| Interaction | RGPD8 interactions | 1.54e-09 | 74 | 57 | 7 | int:RGPD8 | |
| Interaction | RGPD5 interactions | 9.70e-09 | 96 | 57 | 7 | int:RGPD5 | |
| Interaction | KIAA2013 interactions | 3.63e-08 | 116 | 57 | 7 | int:KIAA2013 | |
| Interaction | NPIPB6 interactions | 1.71e-07 | 18 | 57 | 4 | int:NPIPB6 | |
| Interaction | TCIRG1 interactions | 5.13e-05 | 72 | 57 | 4 | int:TCIRG1 | |
| Interaction | ESRP1 interactions | 6.67e-05 | 77 | 57 | 4 | int:ESRP1 | |
| Interaction | RANBP2 interactions | 6.84e-05 | 361 | 57 | 7 | int:RANBP2 | |
| Interaction | CMTM6 interactions | 1.17e-04 | 89 | 57 | 4 | int:CMTM6 | |
| Interaction | NEMP1 interactions | 1.17e-04 | 89 | 57 | 4 | int:NEMP1 | |
| Cytoband | 2q13 | 9.52e-05 | 68 | 59 | 3 | 2q13 | |
| Cytoband | 4p16.1 | 1.49e-04 | 79 | 59 | 3 | 4p16.1 | |
| Cytoband | 2q12.3 | 2.18e-04 | 17 | 59 | 2 | 2q12.3 | |
| Cytoband | 11q13.2 | 1.69e-03 | 47 | 59 | 2 | 11q13.2 | |
| Cytoband | 9q34 | 2.23e-03 | 54 | 59 | 2 | 9q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q13 | 2.65e-03 | 59 | 59 | 2 | chr2q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | 2.97e-03 | 222 | 59 | 3 | chr4p16 | |
| Cytoband | 17q21 | 3.02e-03 | 63 | 59 | 2 | 17q21 | |
| Cytoband | 2p11.2 | 3.11e-03 | 64 | 59 | 2 | 2p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q12 | 5.05e-03 | 82 | 59 | 2 | chr2q12 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.09e-10 | 115 | 39 | 8 | 769 | |
| GeneFamily | V-type ATPases | 1.60e-05 | 23 | 39 | 3 | 415 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 2.95e-04 | 12 | 39 | 2 | 670 | |
| GeneFamily | T-boxes | 6.79e-04 | 18 | 39 | 2 | 766 | |
| GeneFamily | Cyclin dependent kinases | 1.43e-03 | 26 | 39 | 2 | 496 | |
| GeneFamily | Cyclins|Mediator complex | 2.29e-03 | 33 | 39 | 2 | 1061 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 5.41e-12 | 43 | 58 | 7 | MM3857 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 9.51e-11 | 33 | 58 | 6 | MM477 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D | RGPD4 RGPD2 NUDT12 RANBP2 ZBTB38 TTC41P RGPD8 RGPD3 CAPN3 RGPD1 PCYOX1 | 3.37e-06 | 888 | 58 | 11 | MM1315 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 9.36e-06 | 474 | 58 | 8 | M40991 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 4.79e-05 | 435 | 58 | 7 | MM1221 | |
| Coexpression | GSE22886_TH1_VS_TH2_48H_ACT_DN | 8.12e-05 | 200 | 58 | 5 | M4512 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.39e-07 | 200 | 58 | 6 | 0bfd41c12887479ceb62c3db0a3c3ba5007eb62b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.39e-07 | 200 | 58 | 6 | 159377d904394d91e09913131e9a93e08189955a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.39e-06 | 194 | 58 | 5 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.81e-06 | 197 | 58 | 5 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.95e-06 | 198 | 58 | 5 | bdabdb11217ea16e5863aa6bfb0f04d48b17f81e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.25e-06 | 200 | 58 | 5 | d30316836494f33ca46d4e415fd2ed179e9cb5ee | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.25e-06 | 200 | 58 | 5 | 091a18d6efed81cab99955c3047f172170f70476 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.25e-06 | 200 | 58 | 5 | 3b8513defe25262ab4b492345b2628570eaefd17 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-05 | 162 | 58 | 4 | 36ddebe3bb172c992739353b7b049b2dde98b559 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.27e-05 | 182 | 58 | 4 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-05 | 183 | 58 | 4 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-05 | 183 | 58 | 4 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 185 | 58 | 4 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 187 | 58 | 4 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.14e-04 | 192 | 58 | 4 | 8dc3016601148243196e925641c9507e9d58c9e0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-04 | 193 | 58 | 4 | 947200ef6c3a2e35ad7e6b4af29d92384bdf73f5 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-04 | 195 | 58 | 4 | 4d7ca21f14730e1b6d0473bc1a11aa626db948f3 | |
| ToppCell | (0)_NK_cells-(0)_NK_CD160pos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.21e-04 | 195 | 58 | 4 | 6cbeceb52bb207f3c074e57b5b3f7cfb24fd5877 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-epithelial_cell-epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-04 | 195 | 58 | 4 | 8727554ef047ca7f1d4b888a8468f148c64a6918 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-epithelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 195 | 58 | 4 | 9f0ee826d4f0997aee8d63284ed24549bbdf6a28 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-04 | 197 | 58 | 4 | 032ccc91e604113da9bc34a6f9ddb1d45dea1892 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-04 | 197 | 58 | 4 | 54fb207638e211f8efdb13003ae62a6b1f003b09 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-04 | 199 | 58 | 4 | 214a6a267e77e5508867b9eb48c4fbc7855ed0a0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-04 | 199 | 58 | 4 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-04 | 199 | 58 | 4 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-04 | 199 | 58 | 4 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-04 | 199 | 58 | 4 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.33e-04 | 200 | 58 | 4 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.33e-04 | 200 | 58 | 4 | 3ce8a2db8c25e1169a0a544f644a63104749c5ee | |
| Drug | WIN 52035 | 1.56e-07 | 5 | 58 | 3 | CID000001786 | |
| Disease | autosomal recessive osteopetrosis 1 (implicated_via_orthology) | 6.46e-08 | 5 | 56 | 3 | DOID:0110942 (implicated_via_orthology) | |
| Disease | renal tubular acidosis (implicated_via_orthology) | 3.60e-07 | 8 | 56 | 3 | DOID:14219 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy 87 (implicated_via_orthology) | 3.54e-06 | 2 | 56 | 2 | DOID:0112221 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 9.17e-06 | 69 | 56 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | 9.28e-05 | 46 | 56 | 3 | DOID:5426 (implicated_via_orthology) | |
| Disease | alcohol and nicotine codependence | 2.72e-04 | 13 | 56 | 2 | EFO_0004776 | |
| Disease | response to diuretic | 8.72e-04 | 23 | 56 | 2 | GO_0036270 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.24e-03 | 111 | 56 | 3 | EFO_0004530, EFO_0008595 | |
| Disease | coronary aneurysm | 2.02e-03 | 35 | 56 | 2 | EFO_1000881 | |
| Disease | adiponectin measurement | 2.72e-03 | 146 | 56 | 3 | EFO_0004502 | |
| Disease | Drug-induced agranulocytosis, response to clozapine | 2.90e-03 | 42 | 56 | 2 | GO_0097338, HP_0012235 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QYLKAFLAAVLGWHL | 321 | O00590 | |
| LSHSDRKVWLLFDYA | 86 | Q9BWU1 | |
| LRWSSDHAYNRKGFK | 2446 | Q7Z408 | |
| SSALVMLAARHYWNA | 1026 | Q8IYW2 | |
| SVVSYWNLALIFHRK | 676 | P49792 | |
| SVVSYWNLALIFHRK | 676 | Q99666 | |
| SVVSYWNLALIFHRK | 676 | O14715 | |
| AYLHLEKADSWQRPF | 786 | Q9ULE6 | |
| VQVVKWYLSAFHAGR | 431 | Q96SU4 | |
| AYAARRAHFWKQVLG | 101 | Q8TAT2 | |
| LRHNAYVAAWRFDQK | 236 | Q5VUB5 | |
| KIETLRFAHNYIWAL | 121 | Q9Y4Z2 | |
| AHTTWRDLFYKLAEA | 151 | Q8IXH7 | |
| LAAHFRGQIYWAKDI | 166 | O43292 | |
| AGYWNSLFRFKHLAT | 296 | Q14643 | |
| FHLAKIKVRNYWTAD | 566 | O60303 | |
| DFWALYSHIQLASKL | 96 | A6NMX2 | |
| LYFHIRWGFSKQVVA | 166 | O00180 | |
| AFFYNRSGKHLATEW | 31 | Q92633 | |
| AIAAHNAALLAYHRW | 471 | Q9UHG3 | |
| ADWKIFYFLRSLHRN | 66 | Q9H4M3 | |
| YINLADHWKALAFRL | 101 | Q9UKM7 | |
| KSVVSYWNLALIFHR | 676 | A6NKT7 | |
| AIEANSSYFHLAAWA | 346 | Q9ULW2 | |
| NAYFSNEHSRLLLLW | 286 | Q5TZA2 | |
| YLQKNADAAFLRHWK | 1916 | Q9ULT8 | |
| YALHSFASRQLKQWR | 1151 | Q9Y6J0 | |
| HARSWHSYDSLFRKK | 201 | Q9H227 | |
| IYFAHTALKWIERAN | 526 | P01133 | |
| RHVLAAWALGAKAFY | 296 | P09172 | |
| AFYLARTAKALQAHW | 241 | Q96EZ8 | |
| HRNEFWSALLEKAYA | 196 | P20807 | |
| LSHADRKVWLLFDYA | 86 | P49336 | |
| VNHSWSELYSFALFK | 406 | Q9UL51 | |
| YAHLQRSFWALAQKV | 296 | Q9BZF2 | |
| KSVVSYWNLALIFHR | 666 | P0DJD0 | |
| QYATDFLLLARHLSW | 1251 | Q8NET4 | |
| VILLHWYANVFNSAL | 61 | P0DSN6 | |
| KSVVSYWNLALIFHR | 676 | Q7Z3J3 | |
| VVSYWNLALIFHRKA | 676 | P0DJD1 | |
| AVFWGYKHIANLLAT | 86 | Q9BQG2 | |
| ALFIWAAHTNRKEYT | 231 | Q9NY35 | |
| AYWNGKLLRSHSQAS | 126 | Q9P2M7 | |
| RYAFHSSAWLVAGKA | 126 | O75333 | |
| AVFVRYNHKTDAALW | 31 | Q9H310 | |
| NKILYLIQAWAHAFR | 106 | O14964 | |
| LYLRGEWQFNHFSKL | 6 | A8MUK1 | |
| YKVTALHWAAFRNAT | 636 | Q6P2S7 | |
| VLIIHLKRYSFNNAW | 506 | Q9HBJ7 | |
| LLDFVAADNHRWKYV | 91 | O15178 | |
| GASYAWHFEARKSQI | 371 | Q63HK5 | |
| ASYLRLWALSLAHAQ | 736 | Q93050 | |
| FKQTARLWAHVYAGA | 141 | P61086 | |
| LYLRGEWQFNHFSKL | 6 | Q0WX57 | |
| AYGRAFNWSSTLNKH | 141 | Q03924 | |
| LAASSLYFKNIFWSH | 51 | Q8NAP3 | |
| LYLRGEWQFNHFSKL | 6 | Q6QN14 | |
| AWAYTIFENIKIFHS | 436 | Q2TAA8 | |
| LRLHWVEFQNKFYSG | 801 | Q13488 | |
| ASYLRLWALSLAHAQ | 751 | Q9Y487 |